
Leads Biolabs
维立志博
Leads Biolabs
Biotech/Healthcare
Willead Biotech is a developer of novel antibody therapeutics focused on oncology, autoimmune diseases, and infectious diseases. Centered on cancer immunotherapy, the company develops and commercializes proprietary antibody drugs and has built an intellectual property-backed pipeline primarily…
Latest round: Series D (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.